鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/01/15 | 2,488 | 2,596 | 2,486 | 2,522 | -7 | -0.3% | 27,600 |
2019/01/11 | 2,530 | 2,534 | 2,472 | 2,529 | -21 | -0.8% | 36,900 |
2019/01/10 | 2,550 | 2,566 | 2,529 | 2,550 | ±0 | ±0% | 22,400 |
2019/01/09 | 2,521 | 2,572 | 2,514 | 2,550 | +29 | +1.2% | 41,800 |
2019/01/08 | 2,491 | 2,545 | 2,474 | 2,521 | +10 | +0.4% | 41,100 |
2019/01/07 | 2,562 | 2,588 | 2,495 | 2,511 | +24 | +1% | 37,400 |
2019/01/04 | 2,408 | 2,493 | 2,385 | 2,487 | +54 | +2.2% | 37,700 |
2018/12/28 | 2,498 | 2,499 | 2,415 | 2,433 | -67 | -2.7% | 16,000 |
2018/12/27 | 2,467 | 2,500 | 2,407 | 2,500 | +95 | +4% | 46,100 |
2018/12/26 | 2,361 | 2,447 | 2,361 | 2,405 | +28 | +1.2% | 50,600 |
2018/12/25 | 2,439 | 2,439 | 2,365 | 2,377 | -112 | -4.5% | 43,600 |
2018/12/21 | 2,543 | 2,543 | 2,417 | 2,489 | -55 | -2.2% | 50,300 |
2018/12/20 | 2,602 | 2,627 | 2,543 | 2,544 | -85 | -3.2% | 43,700 |
2018/12/19 | 2,570 | 2,685 | 2,537 | 2,629 | +29 | +1.1% | 72,800 |
2018/12/18 | 2,600 | 2,631 | 2,562 | 2,600 | -44 | -1.7% | 46,900 |
2018/12/17 | 2,635 | 2,698 | 2,623 | 2,644 | -18 | -0.7% | 48,200 |
2018/12/14 | 2,685 | 2,685 | 2,642 | 2,662 | -20 | -0.7% | 51,300 |
2018/12/13 | 2,600 | 2,719 | 2,600 | 2,682 | +92 | +3.6% | 95,800 |
2018/12/12 | 2,499 | 2,620 | 2,483 | 2,590 | +121 | +4.9% | 98,800 |
2018/12/11 | 2,445 | 2,499 | 2,400 | 2,469 | +50 | +2.1% | 47,100 |
2018/12/10 | 2,524 | 2,524 | 2,412 | 2,419 | -55 | -2.2% | 70,400 |
2018/12/07 | 2,507 | 2,536 | 2,340 | 2,474 | -111 | -4.3% | 176,900 |
2018/12/06 | 2,536 | 2,589 | 2,523 | 2,585 | +58 | +2.3% | 50,500 |
2018/12/05 | 2,524 | 2,567 | 2,517 | 2,527 | -12 | -0.5% | 43,300 |
2018/12/04 | 2,516 | 2,584 | 2,510 | 2,539 | -15 | -0.6% | 79,400 |
2018/12/03 | 2,480 | 2,591 | 2,480 | 2,554 | -76 | -2.9% | 251,600 |
2018/11/30 | 2,350 | 2,666 | 2,350 | 2,630 | +326 | +14.1% | 520,300 |
2018/11/29 | 2,330 | 2,349 | 2,301 | 2,304 | -26 | -1.1% | 23,200 |
2018/11/28 | 2,314 | 2,349 | 2,310 | 2,330 | +16 | +0.7% | 20,100 |
2018/11/27 | 2,299 | 2,319 | 2,283 | 2,314 | +15 | +0.7% | 26,600 |
2018/11/26 | 2,275 | 2,321 | 2,275 | 2,299 | +9 | +0.4% | 27,000 |
2018/11/22 | 2,228 | 2,306 | 2,228 | 2,290 | -6 | -0.3% | 83,100 |
2018/11/21 | 2,327 | 2,327 | 2,295 | 2,296 | -36 | -1.5% | 43,800 |
2018/11/20 | 2,372 | 2,372 | 2,323 | 2,332 | -48 | -2% | 23,800 |
2018/11/19 | 2,397 | 2,398 | 2,370 | 2,380 | -33 | -1.4% | 34,100 |
2018/11/16 | 2,393 | 2,429 | 2,386 | 2,413 | +20 | +0.8% | 20,700 |
2018/11/15 | 2,381 | 2,406 | 2,379 | 2,393 | -12 | -0.5% | 19,300 |
2018/11/14 | 2,402 | 2,409 | 2,363 | 2,405 | +23 | +1% | 44,000 |
2018/11/13 | 2,377 | 2,402 | 2,366 | 2,382 | -9 | -0.4% | 38,100 |
2018/11/12 | 2,390 | 2,408 | 2,373 | 2,391 | -17 | -0.7% | 17,300 |
2018/11/09 | 2,419 | 2,471 | 2,407 | 2,408 | -21 | -0.9% | 25,100 |
2018/11/08 | 2,410 | 2,456 | 2,410 | 2,429 | +53 | +2.2% | 29,300 |
2018/11/07 | 2,378 | 2,408 | 2,362 | 2,376 | -6 | -0.3% | 27,600 |
2018/11/06 | 2,377 | 2,420 | 2,371 | 2,382 | +51 | +2.2% | 36,200 |
2018/11/05 | 2,331 | 2,372 | 2,296 | 2,331 | +45 | +2% | 64,300 |
2018/11/02 | 2,311 | 2,320 | 2,260 | 2,286 | -14 | -0.6% | 119,700 |
2018/11/01 | 2,637 | 2,637 | 2,300 | 2,300 | -187 | -7.5% | 128,400 |
2018/10/31 | 2,453 | 2,526 | 2,453 | 2,487 | +42 | +1.7% | 38,400 |
2018/10/30 | 2,431 | 2,482 | 2,421 | 2,445 | -11 | -0.4% | 45,100 |
2018/10/29 | 2,435 | 2,517 | 2,401 | 2,456 | +8 | +0.3% | 47,000 |
1551~
1600
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム